Product Information
Name:CD 10899
Brand:Targetmol
Description:CD 10899, a hydroxylated metabolite of Volasertib, is pharmacologically active against Polo-like kinase 1 (PLK1) with an IC50 of 6 nM. Volasertib is an orally active, highly potent, and ATP-competitive PLK1 inhibitor. CD 10899 can be used for cancer research [1].
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:634.81
Formula:C34H50N8O4
Color/Form:Solid
Technical inquiry about: CD 10899
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.